BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/19/2018 9:46:49 AM | Browse: 1126 | Download: 1216
 |
Received |
|
2017-11-07 05:48 |
|
Peer-Review Started |
|
2017-11-07 08:02 |
|
To Make the First Decision |
|
2017-11-30 06:02 |
|
Return for Revision |
|
2017-12-01 09:32 |
|
Revised |
|
2017-12-05 19:10 |
|
Second Decision |
|
2017-12-12 08:42 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-12-12 19:42 |
|
Articles in Press |
|
2017-12-12 19:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-01-05 07:02 |
|
Publish the Manuscript Online |
|
2018-01-19 09:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chiranjeevi Gadiparthi, George Cholankeril, Brandon J Perumpail, Eric R Yoo, Sanjaya Kumar Satapathy, Satheesh Nair and Aijaz Ahmed |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Aijaz Ahmed, MD, Associate Professor, Attending Doctor, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 750 Welch Road, Suite 210, Palo Alto, CA 94304, United States. aijazahmed@stanford.edu |
| Key Words |
Hepatitis C virus; Direct-acting antiviral therapy; Liver transplantation; Purgatory Model for End-stage liver disease; Sustained virological response |
| Core Tip |
Optimal timing of antiviral therapy for hepatitis C virus (HCV) infection in liver transplant candidates using second generation direct-acting antivirals is debated. Available evidence lacks conviction if the viral eradication is beneficial in all HCV patients before liver transplantation. We aim to review the current literature to better delineate the appropriate timing of HCV treatment in the era of direct-acting antiviral agents. |
| Publish Date |
2018-01-19 09:46 |
| Citation |
Gadiparthi C, Cholankeril G, Perumpail BJ, Yoo ER, Satapathy SK, Nair S, Ahmed A. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates. World J Gastroenterol 2018; 24(3): 315-322 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i3/315.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i3.315 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
